US2814294A - Unit for and method of inhibiting and controlling bleeding tendencies - Google Patents

Unit for and method of inhibiting and controlling bleeding tendencies Download PDF

Info

Publication number
US2814294A
US2814294A US349371A US34937153A US2814294A US 2814294 A US2814294 A US 2814294A US 349371 A US349371 A US 349371A US 34937153 A US34937153 A US 34937153A US 2814294 A US2814294 A US 2814294A
Authority
US
United States
Prior art keywords
placque
plug
needle
unit
inhibiting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US349371A
Inventor
Frank H J Figge
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Becton Dickinson and Co
Original Assignee
Becton Dickinson and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Becton Dickinson and Co filed Critical Becton Dickinson and Co
Priority to US349371A priority Critical patent/US2814294A/en
Application granted granted Critical
Publication of US2814294A publication Critical patent/US2814294A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests

Definitions

  • This invention relates to a structurally and functionally improved placque or unit for use in connection with hypo dermic injections and also teaches a technique to be followed in the use of the placque and the achievement of the injection in a manner such that bleeding tendencies will be inhibited and controlled aside from the fact that damaging effects will also be controlled.
  • Fig. 1 is a perspective view of one form of placque assembly
  • Fig. 2 is a sectional side view taken along the line 2-2 and in the direction of the arrows as indicated in Fig. 1;
  • Fig. 3 shows the unit in section and applied to the site to be injected
  • Figs. 4 to 8 inclusive are views similar to Fig. 3 but showing the successive steps involved under velocity injection technique.
  • Fig. 9 is a view similar to Fig. 3 butshowing the procedure embraced under hypodermic injections achieved by the use of needles.
  • a unit which includes, for eX- ample, a plastic or cloth strip 10 of any desired contour and which has applied to its inner face a layer 11 of'adesive to which is attached disk of placque layer 12 covered by a protecting strip 13 which has its edge zones preferably in engagement with the adhesive layer.
  • the outer face of strip 10 may present a convex or domed portion 14 provided with a centrally located aperture 15.
  • the outer face of the strip may be protected by a. covering layer (not shown).
  • a. covering layer not shown.
  • the parts embrace a grouping such as afore described.
  • the material of which the placque is formed should be absorbable so that when particles are dislodged and carried into the body of t e patient, these particles will be absorbed in a natural way leaving no residue and without exciting much, if any, foreign body reaction or scar tissue formation.
  • the placque should be constructed of non-sensitizing, non-allergenic material or of material proven to be essentially non-antigenic. This material should additionally be sterile and capable of treatment with an appropriate anti-biotic, antiseptic or local anesthetic or any other desired agents. This will, for example, minimize contamination with bacteria or other organisms and/or pain during or after the injection.
  • the material in addition to being severable, should also be hemos-tatie or promote the clotting of blood especially if particles of such material are carried into and lodge in the intra-tissue opening or channel made by the needle, jet or other penetrating device.
  • One material embodying the desired characteristics is a heat-sterilized foam sponge made of animal gelatin. This has the characteristics of flexibility and is capable of being left in situ.
  • a material of similar type is an absorbable brin foam made from human plasma. Materials of this type do not induce inammation and are completely absorbed within a reasonable period of time. The material may be used alone, with thrombin, with saline solution or with antibiotics when indicated.
  • gelatin is first de-natured to decrease its solubility and then worked into a foam. This is poured into molds and hardened into blocks disposed in suitable drying enclosures. These blocks may be cut by slicing machines or otherwise and sterilized.
  • the slices may be subdivided to include areas of desired shape and size. The surface areas of the material act in a manner such that they apparently release thromboplastin which hastens clotting.
  • the dry material effectively serves as a hemostatic matrix.
  • the surface of the site to be injected is swabbed with alcohol, ether, or acetone.
  • the protecting strip 13 of the latter is removed (if the unit embraces a structure such as is generally shown in Fig. 2).
  • placque 12 is brought in direct -contact with the surface of tissue 16 as indicated in Fig. 3 and the parts are maintained in position for example, by the adhesive lever 11.
  • the nozzle 17 of a velocity injection mechanism 18 is introduced through the opening 15 in the manner shown in Fig. 4. That apparatus or gun is now fired As in Fig. 5, the jet of liquid 19 will, under these circumstances, be discharged Ithrough the body of the placque into the underlying tissue 16.
  • the plug will remain adjacent the surface of the tissue at the end of the firing or injection stroke. It will plug the opening or bore formed by jet 19. lt may remain in the position diagrammatically shown in Figs. 7 and 8 or may be closer to or further away from the surface of the tissue. Bleeding or the escape of other body liquids onto the surface of the tissues will be either completely or partially prevented. If some small quantity of body fluid does escape, it will be absorbed immediately by the main portion of z placque 12 remaining on the surface of the/tissues thus protecting clothing from stains. Also, the patient will not be aware of the escape of such fluids to the surface. The placque may remain in position after the injection or, if desired, may be substantially immediately removed. The plug 20, after it has served the desired functions will be absorbed.
  • a hypodermic needle such as 22 in Fig. 9
  • the placque is again applied to the surface of the tissues as heretofore described.
  • the needle is plunged through the opening 15 if a protecting strip 10 is employed.
  • a plug 23 will be cut from the placque either due to the shearing action of the needle edges or else due to the tearing action upon the placque by projecting the needle through the same.
  • the plug 23 has been shown as actually within the bore of the cannula in which case it will bc carried down substantially to the full depth of penetration of the needle.
  • the plug in being torn loose from the placque, would be carried down into the tissues to a lesser depth by frictionally outer face of the needle. ln either event, as the needle is withdrawn, the plug would move to some extent with it towards the tissue surface. More particularly, if the plug were lodged within the bore of the cannula as in Fig. 9, it would be initially discharged as the medicament was injected and would remain adjacent the point of the needle during the injection stroke. As the needle was withdrawn and incident to the natural elasticity of the tissues, the liquid medicament would be under some pressure and tend to escape through the channel or bore created by the needle. In so flowing, the plug would be forced towards the tissue surface.
  • the plug or portion 23 would remain in position during the injection stroke. However, as the needle was withdrawn, the frictional engagement between the same and the plug would tend to move the latter outwardly. Also, the pressure of the medicament attempting to escape, would similarly shift the plug. Therefore, the latter would again assume a position adjacent the surface and perform the desired functions.
  • plug has been employed. This also appears in the appended claims.
  • the term is a convenient one and is to be interpreted generically so as not to be limited to a definite unitary body of material. It is intended to cover also any number of particles which result from the operations afore described. As will be understood, if only a few isolated particles or molecules of the placque are introduced, they will also cause an obstruction to form in the perforation made by either the jet or needle. Even if the particles be microscopic in size and individually far smaller than the opening, the desired result will follow.
  • the absorption of blood at the surface and the stimulation of clotting in the opening of the skin is of primary importance and in certain respects more important than deeper plugging. Concealment of the slight bleeding that may occur is also important both psychologically and for the protection of clothing.
  • a method of inhibiting and controlling the escape of body fluid from a passage formed in tissues incident to the latter having been hypodermically injected including utilizing a placque of absorbent hemostatic material the inner face of which is to be arranged adjacent to the tissue surface, disposing the operative parts of a hypodermic apparatus adjacent the outer placque face, operating said apparatus to sever a plug of material adhering to the from said placque and to cause said plug to be moved inwardly of such inner face and to substantially simultaneously cause liquid medicament to ow through the area of plug severance.
  • a method of inhibiting and controlling the escape of body fluid from a passage formed in tissues incident to the latter having been hypodermically injected including utilizing a placque of absorbent hemostatic material the inner face of which is arranged adjacent to the tissue surface, disposing the operative parts of a hypodermic apparatus adjacent the outer placque face, operating said apparatus to sever a plug of material from said placque and cause said plug to be moved inwardly of such inner face and to substantially simultaneously cause liquid medicament to flow through the area of plug severance and thereafter cause said plug to move towards the surface after completion of the injection.
  • a method of inhibiting and controlling the escape of body uid from a passage formed in tissues incident to the latter having been hypodermically injected including utilizing a placque of absorbent hemostatic material the inner face of which is to be arranged adjacent to the tissue surface, disposing the operative parts of a hypodermic apparatus adjacent the outer placque face, operating said apparatus to sever a plug of material from said placque and cause said plug to be moved inwardly of such inner face and to substantially simultaneously cause the liquid medicament to flow through the area of plug severance and bypassing the plug with the medicament which is being injected.
  • a method of inhibiting and controlling the escape of body fluid from a passage formed in tissues incident to the latter having been hypodermically injected including utilizing a placque of absorbent hemostatic material the inner face of which is arranged adjacent to the tissue surface, disposing the operative parts of a hypodermic apparatus adjacent the outer placque face, operating said apparatus to sever a plug of material from said placque and cause said plug to be moved inwardly of such inner face and to substantially simultaneously cause the liquid medicament to flow through the area of plug severance, bypassing the plug with the medicament which is being injected and allowing said plug to move towards the surface after completion of the injection.
  • a method of inhibiting and controlling the escape of body fluids from a passage formed in tissues incident to the latter having been hypodermically injected including utilizing a placque of absorbent hemostatic material the inner face of which is to be arranged adjacent to the tissue surface, disposing the injection nozzle of a velocity injection apparatus adjacent the outer placque face, operating said apparatus to force a jet of liquid medicament through said placque and simultaneously shear a plug of material therefrom.
  • a method of inhibiting and controlling the escape of body fluids from a passage formed in tissues incident to the latter having been hypodermically injected including utilizing a placque of absorbent hemostatic material the inner face of which is to be arranged adjacent to the tissue surface, plunging the point of a hypodermic needle through the outer placque face and through the plaque body, simultaneously removing a plug of placque material incident to such plunging action and projection of the needle, forcing liquid medicament through said needle and thereupon retracting the needle with respect to the plaque and plug.
  • a unit of the character described including in combination a placque of material transversely shearable to provide a plug section, said material having hemostatic and absorbent characteristics, means in contact with said placque for securing the latter in direct engagement with the surface of tissue to be hypodermically injected, and said securing means extending to one side of the area of plug shearing, whereby a plug of material may be injected into the tissue free from any part of the material constituting said securing means.
  • a unit of the character described including in cornbination a piacque of material, said placque presenting an inner face to be applied to tissues to be injected, said material having hemostatic characteristics and being absorbable into human tissues, means attached to said placque for supporting the same, whereby said piacque may be disposed in direct face-to-face contact with the surface which it is to overlie and said supporting means being provided with an opening in line with said placque material through which opening the activating cause of a hypodermic injection assembly may pass to shear a plug of placque material and inject it together with medicament into tissues below such surface.

Description

Nov. 26, 1957 F. H. J. FIGGE 2,814,294
UNIT FOR AND METHOD oF INHIBITING AND CONTROLLING BLEEDING TENDENDIES Filed April 17. 195s IN V EN TOR. @m1/Hf IM? BY United States Patent UNIT FOR AND METHOD F INHIBITING AND CONTROLLING BLEEDING TENDENCIES Frank H. J. Figge, Baltimore, Md., assignor to Becton, Dickinson and Company, Rutherford, N. J., a corporation of New Jersey Application April 17, 1953, Serial No. 349,371 8 Claims. (Cl. 12S-215) This invention relates to a structurally and functionally improved placque or unit for use in connection with hypo dermic injections and also teaches a technique to be followed in the use of the placque and the achievement of the injection in a manner such that bleeding tendencies will be inhibited and controlled aside from the fact that damaging effects will also be controlled.
By means of the present teachings, a unit is produced which will be capable of achieving the desired results and which unit will be quite inexpensive aside from the fact that it may be employed with facility by persons having no special technical skills.
With these and other objects in mind, reference is had to the attached sheet of drawings illustrating a practical embodiment of the invention and the procedure to be followed in using the same and in which:
Fig. 1 is a perspective view of one form of placque assembly;
Fig. 2 is a sectional side view taken along the line 2-2 and in the direction of the arrows as indicated in Fig. 1;
Fig. 3 shows the unit in section and applied to the site to be injected;
Figs. 4 to 8 inclusive are views similar to Fig. 3 but showing the successive steps involved under velocity injection technique; and
Fig. 9 is a view similar to Fig. 3 butshowing the procedure embraced under hypodermic injections achieved by the use of needles.
ln connection with hypodermicinjections and including especially Ithose achieved by Velocity injection, it has been noted that bleeding from the site of injection is a common occurrence. Also, after needle-type injections, a slight amount of bleeding is frequently observed. By means of the present teachings, bleeding will be complete ly or partially inhibited. If, however, some bleeding does occur, the relatively small quantity of blood will be absorbed immediately, thus protecting clothing from blood stains. Additionally, the patient will not be aware that bleeding has occurred.
Referring primarily to Figs. 1 and 2 of the annexed drawings, a unit has been shown which includes, for eX- ample, a plastic or cloth strip 10 of any desired contour and which has applied to its inner face a layer 11 of'adesive to which is attached disk of placque layer 12 covered by a protecting strip 13 which has its edge zones preferably in engagement with the adhesive layer.
The outer face of strip 10 may present a convex or domed portion 14 provided with a centrally located aperture 15. The outer face of the strip may be protected by a. covering layer (not shown). Under certain conditions, it would be feasible merely to employ theplacque 12 in order to achieve at least certain of the advantages inherent to the present teachings. However, for the purpose of providing a unitary and readily handled unit, it is preferred that the parts embrace a grouping such as afore described.
The material of which the placque is formed should be absorbable so that when particles are dislodged and carried into the body of t e patient, these particles will be absorbed in a natural way leaving no residue and without exciting much, if any, foreign body reaction or scar tissue formation. Also, the placque should be constructed of non-sensitizing, non-allergenic material or of material proven to be essentially non-antigenic. This material should additionally be sterile and capable of treatment with an appropriate anti-biotic, antiseptic or local anesthetic or any other desired agents. This will, for example, minimize contamination with bacteria or other organisms and/or pain during or after the injection. Finally, the material, in addition to being severable, should also be hemos-tatie or promote the clotting of blood especially if particles of such material are carried into and lodge in the intra-tissue opening or channel made by the needle, jet or other penetrating device.
One material embodying the desired characteristics is a heat-sterilized foam sponge made of animal gelatin. This has the characteristics of flexibility and is capable of being left in situ. A material of similar type is an absorbable brin foam made from human plasma. Materials of this type do not induce inammation and are completely absorbed within a reasonable period of time. The material may be used alone, with thrombin, with saline solution or with antibiotics when indicated. According to one method of procedure, resulting in a material of the desired characteristics, gelatin is first de-natured to decrease its solubility and then worked into a foam. This is poured into molds and hardened into blocks disposed in suitable drying enclosures. These blocks may be cut by slicing machines or otherwise and sterilized. The slices may be subdivided to include areas of desired shape and size. The surface areas of the material act in a manner such that they apparently release thromboplastin which hastens clotting. The dry material effectively serves as a hemostatic matrix.
In proceeding, the surface of the site to be injected is swabbed with alcohol, ether, or acetone. The several parts of the placque unit, having all been sterilized, the protecting strip 13 of the latter is removed (if the unit embraces a structure such as is generally shown in Fig. 2). Thereupon, placque 12 is brought in direct -contact with the surface of tissue 16 as indicated in Fig. 3 and the parts are maintained in position for example, by the adhesive lever 11. The nozzle 17 of a velocity injection mechanism 18 is introduced through the opening 15 in the manner shown in Fig. 4. That apparatus or gun is now fired As in Fig. 5, the jet of liquid 19 will, under these circumstances, be discharged Ithrough the body of the placque into the underlying tissue 16. So discharged, it will sever a plug 20 from the placque and carry it into the tissue 16 to a certain depth. This penetration of the tissues by the plug may occur for only a relatively shallow depth. As shown in Fig. 6, -the liquid medicament comprising jet 19 will penetrate these tissues to a far greater depth and in a desired pattern according to the characteristics of the injection apparatus. So flowing the medicament, generally indicated by the arrows at 21, will in eifect by-pass plug 20.
Therefore, as shown in Fig. 7, the plug will remain adjacent the surface of the tissue at the end of the firing or injection stroke. It will plug the opening or bore formed by jet 19. lt may remain in the position diagrammatically shown in Figs. 7 and 8 or may be closer to or further away from the surface of the tissue. Bleeding or the escape of other body liquids onto the surface of the tissues will be either completely or partially prevented. If some small quantity of body fluid does escape, it will be absorbed immediately by the main portion of z placque 12 remaining on the surface of the/tissues thus protecting clothing from stains. Also, the patient will not be aware of the escape of such fluids to the surface. The placque may remain in position after the injection or, if desired, may be substantially immediately removed. The plug 20, after it has served the desired functions will be absorbed.
If an injection is to be made by a hypodermic needle, such as 22 in Fig. 9, then the placque is again applied to the surface of the tissues as heretofore described. The needle is plunged through the opening 15 if a protecting strip 10 is employed. In so projecting the needle, a plug 23 will be cut from the placque either due to the shearing action of the needle edges or else due to the tearing action upon the placque by projecting the needle through the same. In Fig. 9, the plug 23 has been shown as actually within the bore of the cannula in which case it will bc carried down substantially to the full depth of penetration of the needle. If not so positioned, the plug, in being torn loose from the placque, would be carried down into the tissues to a lesser depth by frictionally outer face of the needle. ln either event, as the needle is withdrawn, the plug would move to some extent with it towards the tissue surface. More particularly, if the plug were lodged within the bore of the cannula as in Fig. 9, it would be initially discharged as the medicament was injected and would remain adjacent the point of the needle during the injection stroke. As the needle was withdrawn and incident to the natural elasticity of the tissues, the liquid medicament would be under some pressure and tend to escape through the channel or bore created by the needle. In so flowing, the plug would be forced towards the tissue surface.
Obviously, if the plug or portion 23 were outside of the bore of the cannula and between it and the adjacent tissue surface, it would remain in position during the injection stroke. However, as the needle was withdrawn, the frictional engagement between the same and the plug would tend to move the latter outwardly. Also, the pressure of the medicament attempting to escape, would similarly shift the plug. Therefore, the latter would again assume a position adjacent the surface and perform the desired functions.
Throughout the specification, the designation plug has been employed. This also appears in the appended claims. The term is a convenient one and is to be interpreted generically so as not to be limited to a definite unitary body of material. It is intended to cover also any number of particles which result from the operations afore described. As will be understood, if only a few isolated particles or molecules of the placque are introduced, they will also cause an obstruction to form in the perforation made by either the jet or needle. Even if the particles be microscopic in size and individually far smaller than the opening, the desired result will follow. The absorption of blood at the surface and the stimulation of clotting in the opening of the skin is of primary importance and in certain respects more important than deeper plugging. Concealment of the slight bleeding that may occur is also important both psychologically and for the protection of clothing.
Thus, among others, the several objects of the invention as specifically aforenoted are achieved. It is apparent that the structure of the unit may be varied in numerous respects and the steps of the method might be similarly varied without departing from the spirit of the invention as defined by the claims.
I claim:
l. A method of inhibiting and controlling the escape of body fluid from a passage formed in tissues incident to the latter having been hypodermically injected, said method including utilizing a placque of absorbent hemostatic material the inner face of which is to be arranged adjacent to the tissue surface, disposing the operative parts of a hypodermic apparatus adjacent the outer placque face, operating said apparatus to sever a plug of material adhering to the from said placque and to cause said plug to be moved inwardly of such inner face and to substantially simultaneously cause liquid medicament to ow through the area of plug severance.
2. A method of inhibiting and controlling the escape of body fluid from a passage formed in tissues incident to the latter having been hypodermically injected, said method including utilizing a placque of absorbent hemostatic material the inner face of which is arranged adjacent to the tissue surface, disposing the operative parts of a hypodermic apparatus adjacent the outer placque face, operating said apparatus to sever a plug of material from said placque and cause said plug to be moved inwardly of such inner face and to substantially simultaneously cause liquid medicament to flow through the area of plug severance and thereafter cause said plug to move towards the surface after completion of the injection.
3. A method of inhibiting and controlling the escape of body uid from a passage formed in tissues incident to the latter having been hypodermically injected, said method including utilizing a placque of absorbent hemostatic material the inner face of which is to be arranged adjacent to the tissue surface, disposing the operative parts of a hypodermic apparatus adjacent the outer placque face, operating said apparatus to sever a plug of material from said placque and cause said plug to be moved inwardly of such inner face and to substantially simultaneously cause the liquid medicament to flow through the area of plug severance and bypassing the plug with the medicament which is being injected.
4. A method of inhibiting and controlling the escape of body fluid from a passage formed in tissues incident to the latter having been hypodermically injected, said method including utilizing a placque of absorbent hemostatic material the inner face of which is arranged adjacent to the tissue surface, disposing the operative parts of a hypodermic apparatus adjacent the outer placque face, operating said apparatus to sever a plug of material from said placque and cause said plug to be moved inwardly of such inner face and to substantially simultaneously cause the liquid medicament to flow through the area of plug severance, bypassing the plug with the medicament which is being injected and allowing said plug to move towards the surface after completion of the injection.
5. A method of inhibiting and controlling the escape of body fluids from a passage formed in tissues incident to the latter having been hypodermically injected, said method including utilizing a placque of absorbent hemostatic material the inner face of which is to be arranged adjacent to the tissue surface, disposing the injection nozzle of a velocity injection apparatus adjacent the outer placque face, operating said apparatus to force a jet of liquid medicament through said placque and simultaneously shear a plug of material therefrom.
6. A method of inhibiting and controlling the escape of body fluids from a passage formed in tissues incident to the latter having been hypodermically injected, said method including utilizing a placque of absorbent hemostatic material the inner face of which is to be arranged adjacent to the tissue surface, plunging the point of a hypodermic needle through the outer placque face and through the plaque body, simultaneously removing a plug of placque material incident to such plunging action and projection of the needle, forcing liquid medicament through said needle and thereupon retracting the needle with respect to the plaque and plug.
7. A unit of the character described, including in combination a placque of material transversely shearable to provide a plug section, said material having hemostatic and absorbent characteristics, means in contact with said placque for securing the latter in direct engagement with the surface of tissue to be hypodermically injected, and said securing means extending to one side of the area of plug shearing, whereby a plug of material may be injected into the tissue free from any part of the material constituting said securing means.
8. A unit of the character described, including in cornbination a piacque of material, said placque presenting an inner face to be applied to tissues to be injected, said material having hemostatic characteristics and being absorbable into human tissues, means attached to said placque for supporting the same, whereby said piacque may be disposed in direct face-to-face contact with the surface which it is to overlie and said supporting means being provided with an opening in line with said placque material through which opening the activating cause of a hypodermic injection assembly may pass to shear a plug of placque material and inject it together with medicament into tissues below such surface.
.References Cited in the le of this patent UNITED STATES PATENTS
US349371A 1953-04-17 1953-04-17 Unit for and method of inhibiting and controlling bleeding tendencies Expired - Lifetime US2814294A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US349371A US2814294A (en) 1953-04-17 1953-04-17 Unit for and method of inhibiting and controlling bleeding tendencies

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US349371A US2814294A (en) 1953-04-17 1953-04-17 Unit for and method of inhibiting and controlling bleeding tendencies

Publications (1)

Publication Number Publication Date
US2814294A true US2814294A (en) 1957-11-26

Family

ID=23372118

Family Applications (1)

Application Number Title Priority Date Filing Date
US349371A Expired - Lifetime US2814294A (en) 1953-04-17 1953-04-17 Unit for and method of inhibiting and controlling bleeding tendencies

Country Status (1)

Country Link
US (1) US2814294A (en)

Cited By (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3072121A (en) * 1956-07-24 1963-01-08 Nat Tuberculosis Ass Pellet injector
US4281650A (en) * 1977-07-11 1981-08-04 Cederroths Ab Hermetically sealed compress medical dressing
US4362157A (en) * 1981-02-18 1982-12-07 Keeth John D Template for locating hypodermic injection sites
US4464178A (en) * 1981-11-25 1984-08-07 Dalton Michael J Method and apparatus for administration of fluids
US5349967A (en) * 1993-03-19 1994-09-27 Tennis John M Shield for use by health care personnel during skin injections
US5383898A (en) * 1991-12-13 1995-01-24 Sarfarazi; Faezeh M. Sarfarazi corneal incision closure
US5554106A (en) * 1994-10-13 1996-09-10 Quinton Instrument Company Hydrocolloid exit site dressing
US5569207A (en) * 1994-10-13 1996-10-29 Quinton Instrument Company Hydrocolloid dressing
US5868778A (en) * 1995-10-27 1999-02-09 Vascular Solutions, Inc. Vascular sealing apparatus and method
US5957952A (en) * 1993-05-25 1999-09-28 Vascular Solutions, Inc. Vascular sealing device
US6017359A (en) * 1993-05-25 2000-01-25 Vascular Solutions, Inc. Vascular sealing apparatus
US6071301A (en) * 1998-05-01 2000-06-06 Sub Q., Inc. Device and method for facilitating hemostasis of a biopsy tract
US6162192A (en) * 1998-05-01 2000-12-19 Sub Q, Inc. System and method for facilitating hemostasis of blood vessel punctures with absorbable sponge
US6183497B1 (en) 1998-05-01 2001-02-06 Sub-Q, Inc. Absorbable sponge with contrasting agent
US6200328B1 (en) 1998-05-01 2001-03-13 Sub Q, Incorporated Device and method for facilitating hemostasis of a biopsy tract
US6315753B1 (en) 1998-05-01 2001-11-13 Sub-Q, Inc. System and method for facilitating hemostasis of blood vessel punctures with absorbable sponge
US6540735B1 (en) 2000-05-12 2003-04-01 Sub-Q, Inc. System and method for facilitating hemostasis of blood vessel punctures with absorbable sponge
US6544236B1 (en) 1999-02-10 2003-04-08 Sub-Q, Incorporated Device, system and method for improving delivery of hemostatic material
US6610026B2 (en) 1998-05-01 2003-08-26 Sub-Q, Inc. Method of hydrating a sponge material for delivery to a body
US20040158287A1 (en) * 2000-07-14 2004-08-12 Cragg Andrew H. Sheath-mounted arterial plug delivery device
US6846320B2 (en) 1998-05-01 2005-01-25 Sub-Q, Inc. Device and method for facilitating hemostasis of a biopsy tract
US6849232B2 (en) 2001-03-12 2005-02-01 Sub-Q, Inc. Methods for sterilizing cross-linked gelatin compositions
US6863680B2 (en) 2001-11-08 2005-03-08 Sub-Q, Inc. System and method for delivering hemostasis promoting material to a blood vessel puncture site by fluid pressure
US6984219B2 (en) 1999-09-23 2006-01-10 Mark Ashby Depth and puncture control for blood vessel hemostasis system
US7008440B2 (en) 2001-11-08 2006-03-07 Sub-Q, Inc. System and method for delivering hemostasis promoting material to a blood vessel puncture site by fluid pressure
US7025748B2 (en) 2001-11-08 2006-04-11 Boston Scientific Scimed, Inc. Sheath based blood vessel puncture locator and depth indicator
US7029489B1 (en) 2001-05-18 2006-04-18 Sub-Q, Inc. System and method for delivering hemostasis promoting material to a blood vessel puncture site
US7037323B2 (en) 2001-11-08 2006-05-02 Sub-Q, Inc. Pledget-handling system and method for delivering hemostasis promoting material to a blood vessel puncture site by fluid pressure
US7037322B1 (en) 2001-11-08 2006-05-02 Sub-Q, Inc. System and method for delivering hemostasis promoting material to a blood vessel puncture with a staging tube
US20060116704A1 (en) * 2004-07-15 2006-06-01 Boston Scientific Scimed, Inc. Tissue tract lancet
US7175646B2 (en) 1995-09-15 2007-02-13 Boston Scientific Scimed, Inc. Apparatus and method for percutaneous sealing of blood vessel punctures
US7192436B2 (en) 2001-11-08 2007-03-20 Sub-Q, Inc. Pledget-handling system and method for delivering hemostasis promoting material to a blood vessel puncture site by fluid pressure
US7201725B1 (en) 2000-09-25 2007-04-10 Sub-Q, Inc. Device and method for determining a depth of an incision
US20070213816A1 (en) * 1999-04-09 2007-09-13 Mona Sarfarazi Interior bag for a capsular bag and injector
US20070282373A1 (en) * 2003-11-25 2007-12-06 Mark Ashby Hemostatic Pressure Plug
US7335219B1 (en) 2002-11-04 2008-02-26 Sub-Q, Inc. Hemostatic device including a capsule
US7625352B1 (en) 1998-05-01 2009-12-01 Sub-Q, Inc. Depth and puncture control for system for hemostasis of blood vessel
US7695492B1 (en) 1999-09-23 2010-04-13 Boston Scientific Scimed, Inc. Enhanced bleed back system
US20100211171A1 (en) * 1999-04-09 2010-08-19 Sarfarazi Faezeh M Haptics for accommodative intraocular lens system
US7875043B1 (en) 2003-12-09 2011-01-25 Sub-Q, Inc. Cinching loop
US7955353B1 (en) 2002-11-04 2011-06-07 Sub-Q, Inc. Dissolvable closure device
US8187625B2 (en) 2001-03-12 2012-05-29 Boston Scientific Scimed, Inc. Cross-linked gelatin composition comprising a wetting agent
US8317821B1 (en) 2002-11-04 2012-11-27 Boston Scientific Scimed, Inc. Release mechanism
US20130261567A1 (en) * 2012-03-29 2013-10-03 John Lewis Hogan, III Coagulant substance which will be found at the base of a needle to reduce leakage of fluids, mainly blood from around the insertion base of a needle

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB316112A (en) * 1928-03-23 1929-07-23 Alfred Ernest Marsh Hunn Improvements in or relating to surgical dressings
US2456357A (en) * 1945-10-31 1948-12-14 Allied Chem & Dye Corp Complex resins and process of making
US2533004A (en) * 1943-10-27 1950-12-05 John D Ferry Fibrin clots and methods for preparing the same
DE818079C (en) * 1950-05-12 1951-10-22 Gelatine Fabriken Deutsche Tampon for wound dressings

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB316112A (en) * 1928-03-23 1929-07-23 Alfred Ernest Marsh Hunn Improvements in or relating to surgical dressings
US2533004A (en) * 1943-10-27 1950-12-05 John D Ferry Fibrin clots and methods for preparing the same
US2456357A (en) * 1945-10-31 1948-12-14 Allied Chem & Dye Corp Complex resins and process of making
DE818079C (en) * 1950-05-12 1951-10-22 Gelatine Fabriken Deutsche Tampon for wound dressings

Cited By (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3072121A (en) * 1956-07-24 1963-01-08 Nat Tuberculosis Ass Pellet injector
US4281650A (en) * 1977-07-11 1981-08-04 Cederroths Ab Hermetically sealed compress medical dressing
US4362157A (en) * 1981-02-18 1982-12-07 Keeth John D Template for locating hypodermic injection sites
US4464178A (en) * 1981-11-25 1984-08-07 Dalton Michael J Method and apparatus for administration of fluids
US5383898A (en) * 1991-12-13 1995-01-24 Sarfarazi; Faezeh M. Sarfarazi corneal incision closure
US5349967A (en) * 1993-03-19 1994-09-27 Tennis John M Shield for use by health care personnel during skin injections
US5957952A (en) * 1993-05-25 1999-09-28 Vascular Solutions, Inc. Vascular sealing device
US6017359A (en) * 1993-05-25 2000-01-25 Vascular Solutions, Inc. Vascular sealing apparatus
US5554106A (en) * 1994-10-13 1996-09-10 Quinton Instrument Company Hydrocolloid exit site dressing
US5569207A (en) * 1994-10-13 1996-10-29 Quinton Instrument Company Hydrocolloid dressing
US7175646B2 (en) 1995-09-15 2007-02-13 Boston Scientific Scimed, Inc. Apparatus and method for percutaneous sealing of blood vessel punctures
US5868778A (en) * 1995-10-27 1999-02-09 Vascular Solutions, Inc. Vascular sealing apparatus and method
US20100029908A1 (en) * 1998-05-01 2010-02-04 Boston Scientific Scimed, Inc. Absorbable sponge with contrasting agent
US6610026B2 (en) 1998-05-01 2003-08-26 Sub-Q, Inc. Method of hydrating a sponge material for delivery to a body
US6183497B1 (en) 1998-05-01 2001-02-06 Sub-Q, Inc. Absorbable sponge with contrasting agent
US6200328B1 (en) 1998-05-01 2001-03-13 Sub Q, Incorporated Device and method for facilitating hemostasis of a biopsy tract
US6315753B1 (en) 1998-05-01 2001-11-13 Sub-Q, Inc. System and method for facilitating hemostasis of blood vessel punctures with absorbable sponge
US6440153B2 (en) 1998-05-01 2002-08-27 Sub-Q, Inc. Device and method for facilitating hemostasis of a biopsy tract
US6440151B1 (en) 1998-05-01 2002-08-27 Sub-Q, Inc. Device and method for facilitating hemostasis of a biopsy tract
US6447534B2 (en) 1998-05-01 2002-09-10 Sub-Q, Inc. Device and method for facilitating hemostasis of a biopsy tract
US6527734B2 (en) 1998-05-01 2003-03-04 Sub-Q, Inc. System and method for facilitating hemostasis of blood vessel punctures with absorbable sponge
US7611479B2 (en) 1998-05-01 2009-11-03 Sub-Q, Inc. System and method for facilitating hemostasis of blood vessel punctures with absorbable sponge
US7048710B1 (en) 1998-05-01 2006-05-23 Sub-Q, Inc. System and method for facilitating hemostasis of blood vessel punctures with absorbable sponge
US6086607A (en) * 1998-05-01 2000-07-11 Sub-Q, Inc. Device and method for facilitating hemostasis of a biopsy tract
US7625352B1 (en) 1998-05-01 2009-12-01 Sub-Q, Inc. Depth and puncture control for system for hemostasis of blood vessel
US6846320B2 (en) 1998-05-01 2005-01-25 Sub-Q, Inc. Device and method for facilitating hemostasis of a biopsy tract
US6162192A (en) * 1998-05-01 2000-12-19 Sub Q, Inc. System and method for facilitating hemostasis of blood vessel punctures with absorbable sponge
US7753872B2 (en) 1998-05-01 2010-07-13 Boston Scientific Scimed, Inc. Device, system and method for improving delivery of hemostatic material
US8050741B2 (en) 1998-05-01 2011-11-01 Boston Scientific Scimed, Inc. Device and method for facilitating hemostasis of a biopsy tract
US7618567B2 (en) 1998-05-01 2009-11-17 Boston Scientific Scimed, Inc. Absorbable sponge with contrasting agent
US6071301A (en) * 1998-05-01 2000-06-06 Sub Q., Inc. Device and method for facilitating hemostasis of a biopsy tract
US6544236B1 (en) 1999-02-10 2003-04-08 Sub-Q, Incorporated Device, system and method for improving delivery of hemostatic material
US8556967B2 (en) 1999-04-09 2013-10-15 Faezeh Mona Sarfarazi Interior bag for a capsular bag and injector
US20070213816A1 (en) * 1999-04-09 2007-09-13 Mona Sarfarazi Interior bag for a capsular bag and injector
US20100211171A1 (en) * 1999-04-09 2010-08-19 Sarfarazi Faezeh M Haptics for accommodative intraocular lens system
US9149356B2 (en) 1999-04-09 2015-10-06 Faezeh Mona Sarfarazi Interior bag for a capsular bag and injector
US6984219B2 (en) 1999-09-23 2006-01-10 Mark Ashby Depth and puncture control for blood vessel hemostasis system
US7695492B1 (en) 1999-09-23 2010-04-13 Boston Scientific Scimed, Inc. Enhanced bleed back system
US6964658B2 (en) 2000-05-12 2005-11-15 Sub-Q, Inc. System and method for facilitating hemostasis of blood vessel punctures with absorbable sponge
US6540735B1 (en) 2000-05-12 2003-04-01 Sub-Q, Inc. System and method for facilitating hemostasis of blood vessel punctures with absorbable sponge
US20100049245A1 (en) * 2000-07-14 2010-02-25 Boston Scientific Scimed, Inc. Sheath-mounted arterial plug delivery device
US8696702B2 (en) 2000-07-14 2014-04-15 Boston Scientific Scimed, Inc. Sheath-mounted arterial plug delivery device
US20040158287A1 (en) * 2000-07-14 2004-08-12 Cragg Andrew H. Sheath-mounted arterial plug delivery device
US7621936B2 (en) 2000-07-14 2009-11-24 Boston Scientific Scimed, Inc. Sheath-mounted arterial plug delivery device
US7201725B1 (en) 2000-09-25 2007-04-10 Sub-Q, Inc. Device and method for determining a depth of an incision
US6849232B2 (en) 2001-03-12 2005-02-01 Sub-Q, Inc. Methods for sterilizing cross-linked gelatin compositions
US8524270B2 (en) 2001-03-12 2013-09-03 Boston Scientific Scimed, Inc. Cross-linked gelatin composition coated with a wetting agent
US7264772B2 (en) 2001-03-12 2007-09-04 Boston Scientific Scimed, Inc. Methods for sterilizing cross-linked gelatin compositions
US8821918B2 (en) 2001-03-12 2014-09-02 Boston Scientific Scimed Inc. Cross-linked gelatin composition comprising a wetting agent
US8187625B2 (en) 2001-03-12 2012-05-29 Boston Scientific Scimed, Inc. Cross-linked gelatin composition comprising a wetting agent
US7029489B1 (en) 2001-05-18 2006-04-18 Sub-Q, Inc. System and method for delivering hemostasis promoting material to a blood vessel puncture site
US6863680B2 (en) 2001-11-08 2005-03-08 Sub-Q, Inc. System and method for delivering hemostasis promoting material to a blood vessel puncture site by fluid pressure
US7192436B2 (en) 2001-11-08 2007-03-20 Sub-Q, Inc. Pledget-handling system and method for delivering hemostasis promoting material to a blood vessel puncture site by fluid pressure
US7037322B1 (en) 2001-11-08 2006-05-02 Sub-Q, Inc. System and method for delivering hemostasis promoting material to a blood vessel puncture with a staging tube
US7037323B2 (en) 2001-11-08 2006-05-02 Sub-Q, Inc. Pledget-handling system and method for delivering hemostasis promoting material to a blood vessel puncture site by fluid pressure
US7008440B2 (en) 2001-11-08 2006-03-07 Sub-Q, Inc. System and method for delivering hemostasis promoting material to a blood vessel puncture site by fluid pressure
US7025748B2 (en) 2001-11-08 2006-04-11 Boston Scientific Scimed, Inc. Sheath based blood vessel puncture locator and depth indicator
US7955353B1 (en) 2002-11-04 2011-06-07 Sub-Q, Inc. Dissolvable closure device
US8317821B1 (en) 2002-11-04 2012-11-27 Boston Scientific Scimed, Inc. Release mechanism
US7335219B1 (en) 2002-11-04 2008-02-26 Sub-Q, Inc. Hemostatic device including a capsule
US20070282373A1 (en) * 2003-11-25 2007-12-06 Mark Ashby Hemostatic Pressure Plug
US7875043B1 (en) 2003-12-09 2011-01-25 Sub-Q, Inc. Cinching loop
US20060116704A1 (en) * 2004-07-15 2006-06-01 Boston Scientific Scimed, Inc. Tissue tract lancet
US9808278B2 (en) 2004-07-15 2017-11-07 Boston Scientific Scimed Inc. Tissue tract lancet
US20130261567A1 (en) * 2012-03-29 2013-10-03 John Lewis Hogan, III Coagulant substance which will be found at the base of a needle to reduce leakage of fluids, mainly blood from around the insertion base of a needle

Similar Documents

Publication Publication Date Title
US2814294A (en) Unit for and method of inhibiting and controlling bleeding tendencies
US4936835A (en) Medical needle with bioabsorbable tip
US2561071A (en) Holder for subcutaneous administration of medicaments
US5080655A (en) Medical biopsy needle
US3530492A (en) Method and apparatus for administering hypodermic injections
US5195988A (en) Medical needle with removable sheath
US3358684A (en) Parenteral injection devices
US3490448A (en) Adhesive pressure pad
US5190521A (en) Apparatus and method for raising a skin wheal and anesthetizing skin
US5479936A (en) Biopsy wound closure device and method
US5409466A (en) Transdermal injection appliance
US4534762A (en) Vascular puncture dressing
JP4118399B2 (en) Puncture adjusting tool for injection needle and injection needle assembly including the same
CA2484817A1 (en) Safety injectors
EP0401893A3 (en) Improved sterilizing dressing device for skin puncture
US6502699B1 (en) Method and kit for making injections and withdrawing blood without the use of protective gloves
US20160287794A1 (en) Hypodermic needle system activation mechanism
Travell Factors affecting pain of injection
WO2016072060A1 (en) Microneedle set
US2688968A (en) Hypo jet ampoule
US6524284B1 (en) Medical injection patch
US5496264A (en) Hemostatic transdermal injection appliance
KR910004330B1 (en) Syringe to having mean for preventing re - use
WO2016161062A1 (en) Hypodermic needle system
JPH02232047A (en) Germ-free adhesive foil for medical preparation